|
|
A
Comprehensive Review of Heavy Metal Detoxification and Clinical
Pearls from 30 Years of Medical Practice Dietrich Klinghardt,
MD, PhD
|
| |
|
|
| Dietrich Klinghardt, MD, PhD
|
|
|
|
| |
|
A. Introduction:
Heavy Metals appear in the mammalian system because they have become
part of our environment. We are in a constant exchange with our
environment which is goverened by the laws of osmosis. If mercury
is in the fish we eat, over time we have mercury in our system.
We cannot keep our system pristine and clean, because we are seperated
from our toxic environment only by semi-permeable membranes: skin
and mucosal surfaces. Maintaining relative cleanliness requires
a number of inherent detox systems to work overtime against the
osmotic pressure of the incoming toxins. As the toxixity of our
environment increases so does the osmotic pressure, pushing the
often man- made poisons into our body.
Toxins almost never come alone. They come in synergistically acting
package-deals. Mercury alone is toxic. Together with zinc it is
many times more toxic, add in a little copper and silver, as in
dental amalgam fillings and the detrimental effect to the body increases
manyfold. Together with mercaptan and thioether (dental toxins)
the toxic amalgam effects grow exponentially. Add in a little PCB
and dioxin, as in fish, and the illness causing effect of the methyl
mercury in fish increases manyfold. Toxicology is to a large degree
the study of synergistic effects. In synergy 1 plus 1 = 100. Heavy
metals are primarily neurotoxins. There is a synergistic effect
between all neurotoxins which is responsible for the illness producing
effect.
Making the neurotoxin elimination a major part of my practice has
been an amazing experience. Many illnesses considered intractable
respond when the related issues are successfully resolved.
What are Neurotoxins? Neurotoxins are substances attracted to the
mammalian nervous system. They are absorbed by nerve endings and
travel inside the neuron to the cell body. On their way they distrupt
vital functions of the nerve cell, such as axonal transport of nutrients,
mitochondrial respiration and proper DNA transcription. The body
is constantly trying to eliminate neurotoxins via the available
exit routes: the liver, kidney, skin and exhaled air. Detox mechanisms
include acetylation, sulfation, glucuronidation, oxidation and others.
The liver is most important in these processes. Here most elimination
products are expelled with the bile into the small intestine and
should leave the body via the digestive tract. However, because
of the lipophilic/neurotropic nature of the neurotoxins, most are
reabsorbed by the abundant nerve endings of the enteric nervous
system (ENS) in the intestinal wall. The ENS has more neurons than
the spinal chord. From the moment of mucosal uptake the toxins can
potentially take 4 different paths:
- Neuronal uptake and via axonal transport to the spinal chord
(sympathetic neurons) or brainstem (parasympathetics) - from here
back to the brain
- Venous uptake and via the portal vein back to the liver
- Lymphatic uptake and via the thoracic duct to the subclavian
vein
- Uptake by bowel bacteria and tissues of the intestinal tract
Here is an incomplete list of common neurotoxins in order of importance:
|
|
i)
|
Heavy metals: |
| |
mercury, lead, cadmium, iron, manganese and
aluminum (are the most common). |
| |
Common Sources: metallic mercury vapor escapes
from dental amalgam fillings (they contain about 50% mercury,
the rest is zinc, silver copper, tin and trace metals). Cadmium:
car fumes, cigarette smoke, pigment in oil paint Lead: outasing
from-paint, residues in earth and food chain from time when
lead was used in gasoline, contaminated drinking water Aluminum:
cookware, drinking water |
|
ii)
|
Biotoxins: |
| |
such as tetanus toxin, botulinum toxin (botox),
ascaridin (from intestinal parasites), unspecified toxins from
streptococci, staphylococci, lyme disease, clamydia, tuberculosis,
fungal toxins and toxins produced by viruses. Biotoxins are
minute molecules (200-1000 kilodaltons) containing nitrogen
and sulfur. They belong to a group of chemical messengers which
microorganisms use to control the host´s immune system, host
behaviour and the host´s eating habits. |
|
iii)
|
Xenobiotics (man-made environmental
toxins): |
| |
such as dioxin, formaldehyde, insecticides,
wood preservatives, PCBs etc. |
|
iv)
|
Food Preservatives, excitotoxins and
cosmetics: |
| |
aspartame (diet sweeteners), MSG, many spices,
food colourings, fluoride, methyl-and propyl-paraben, etc. |
|
|
Heavy Metal Toxicity
Metals can exist in the body with different kinds of chemical bonds
and as different molecules. Mercury appears to be the king-pin in
the cascade of events in which metals become pathogenic. Mercury
can be present as metallic mercury (HgO), as mercury salt (e.g.
mercury chloride - HG+), or as methyl mercury (HG++). Methyl mercury
is 50 times more toxic than metallic mercury. Methyl-Hg is so firmly
bound to the body that it has to be first reduced to HG+ before
it can be removed from the cell. This is achieved with reducing
agents ("antioxidants") e.g. intravenous vitamin C and reduced glutathione.
To remove Hg-Salts or metallic Hg from the outside of the cell,
other agents are useful Mercury belongs to a group of metals that
oxidize in the presence of sulfur and form compounds with sulfur
(sulfhydryl affinitive metals). Methyl mercury is already oxidized
to its maximum and bound firmly to sulfur in the different proteins
of the body. The following metals belong to the sulfhydryl affinitive
group and respond to similar detoxification methods: Copper, arsenic,
cadmium, lead, mercury. Aluminum and iron for example would not
respond a sulfur compound. Some detox agents have multiple mechanisms
by which they bind to metals. The algal organism chlorella has over
20 known such mechanisms.
Other metals oxidize with oxygen. Iron turns to rust when oxidized.
Rust is nontoxic to the body, whereas iron is. Iron overdose responds
to a chemical called desferoximin (desferal). Aluminum responds
to the same detoxification agent. A recent Japanese study showed
that Chinese parsley, cilantro, is a powerful elimination agent
for aluminum stored in bone and the brains.
Other facts:
- Some metals are extremely toxic, even in the most minute dose,
whereas others have very low toxicity, even in high doses. However,
dependent on the dose, all metals can become toxic to the body.
Iron can cause severe oxidative damage, copper may compromise
liver function and visual acuity, selenium and arsenic have been
known to be used to murder people and so on.
- Most metals serve a functional role in the body. For example,
selenium is needed in the enzyme that restores oxidized glutathione
back to its functional form as reduced glutathione. Another important
function of selenium is its role as a powerful antioxidant in
preventing cancer.
- Some metals have a narrow physiological range. That means the
difference between a therapeutic dose and toxic overdose is very
small. Selenium is an example of this. Magnesium on the other
hand has a wide physiological range and thus is more difficult
to overdose.
- Some metals have no physiological function. Mercury, lead, aluminum
are in this group. Even the smallest amounts have negative physiological-effects.
" biochemical individuality: some people may react more or less
than others to the presence of heavy metals in the tissues. Some
people may develop a severe chronic illness after exposure of
a few molecules of mercury, whereas others may be more resistant
to it. Genetic deficiencies in the enzymes responsible for the
formation of the metallothioneins and glutathione production and
reduction are examples.
Possible side-effects during heavy metal detox:
- Through their non-specific toxic effects
- Through the system´s allergic reactions to the neurotoxin
Often these two distinctive types of symptoms cannot be easily
distinguished. During a detox program, the patient may also temporarily
become allergic to the various substances that help to carry out
the toxins. This is based on a physiological mechanism called 'operant
conditioning'. Every time the detoxifying substance is given, mercury
emerges from its hiding places into the more superficial tissues
of the body, where mercury can now be detected by the immune system.
The immune system however is fooled into thinking that the detoxifying
substance itself is the enemy. The immune system now starts to react
to the detoxifying substance as if it was the mercury itself. This
reaction typically resolves spontaneously after six weeks of not
using the detox agent in question. This type of conditioned reflex
can also be easily treated with simple techniques e.g. NAET, PK
(APN), or by giving the detox substance in a homeopathic dilution
for a few days. Often the basal membranes in the kidney will swell
as a sign of the allergic reaction, causing low back pain, anuria
or inability to concentrate urine. Neuraltherapy or microcurrent
stimulation of the kidneys quickly resolves the issue. Muscle aches
indicate the redistribution of toxins into the connective tissue
and an insufficient program. Depression, headaches, trigeminal neuralgia,
seizures, increased pain levels indicate redistribution of metals
into the CNS and an inappropriate detox program. Eye problems and
tinnitus that occurs during detox indicates redistribution of metals
into these organs and requires selective mobilization from these
locations before the program is continued. I use a specific type
of microcurrent for this purpose.
Some recently published findings related to the metal issue:
Iron/mangnese: A recent
paper on Parkinsons disease (Neurology June 10, 2003;60:1761-1766)revealed
that just by eating iron and manganese containing foods such as
spinach or taking supplements containing Mn or Fe - the risk of
developing PD increased almost 2 fold. This demonstrates that even
dietary supplements or organically grown foods are amongst the possilbe
culprits in metal toxixity.
Methylmercury: There are two major sources:
- mercury escaped from dental amalgam fillings is converted
by oral and intestinal bacteria to methylmercury, which then is
bound firmly to proteins and other molecules. Methyl mercury crosses
the blodd brain barrier and the placental barrier leading to massive
prenatal exposure. Earlier studies determined that over 90% of
the common body burdon of Hg is from dental fillings. Recent studies
show that eating fish is starting to compete with amalgam fillings
for the leading position as a risk factor.
- Seafood : A recent study (JAMA, April 2, 2003;289(13):1667-1674)
revealed the following It is estimated that nearly 60,000 children
each year are born at risk for neurological problems due to methylmercury
exposure in the womb. One in 12 U.S. women of childbearing age
have potentially hazardous levels of mercury in their blood as
a result of consuming fish, according to government scientists.
The U.S.FDA recommends that pregnant women and those who may become
pregnant avoid eating shark, swordfish, king mackerel, and tile
fish known to contain elevated levels of methylmercury, an organic
form of mercury. Nearly all fish contain some amount of methylmercury.
Mercury accumulates in the system, so larger, longer-lived fish
like shark or swordfish contain the highest amounts of mercury
and pose the largest threat if eaten regularly.
The National Center for Policy Research for Women & Families
published in May 2003, that the following fish are lowest in
methyl mercury:
- Catfish (farmed)
- Blue Crab (mid-Atlantic)
- Croaker
- Fish Sticks
- Flounder (summer)
- Haddock
- Trout (farmed)
- Shrimp The FDA also recommends these fish as safe to eat:
haddock, tilapia, wild alaskan salmon,and sole
Ethylmercury:
A recent quote from Boyd Haley, PhD: "our latest research clearly
points to the ethylmercury exposure as being causal in autism. The
tremendous enhancement of thimerosal toxicity by testosterone and
the reduction of toxicity by estrogen explains the fact that 4 boys
to 1 girl getting the disease and the fact that the bulk of severe
autistics are boys. Most importantly, this autistic situation clearly
shows that exposure to levels of mercury that many "experts" considered
safe was capable of causing an epidemic of a neurological disease".
B. Symptoms:
Other authors have tried to specify typical
symptoms for each metal. Because of the synergistic effects and
simultaneous occurence of several toxins at the same time. The best
source of literature on the effects of specific metals on the system
are the old homeopathic textbooks 'materia medica' (Kent, Boericke).
I prefer to look at a client in a systemic way, not focussing on
single issues . A manganese typical symptom (ie violent behaviour)
may be a lot more worrysome in a given patient then their particular
mercury related symptom (ie insomnia). However, the practical focus
of detox should be almost always on the mercury first. If mercury
is adressed appropriately, the manganese often leaves the body as
a side effect of mercury detox. The opposite is not true.
Any illness can be caused by, or contributed to, or exagerated
by neurotoxins. Here is a short list:
- Neurological problems: Fatigue, depression, insomnia, memory
loss, blunting of the senses, chronic intractable pain (migraine,
sciatica, CTS etc.), burning pain, paresthesia, strange intracranial
sensations and sounds, numbness. Autism. Seizure disorder. Hyperactivity
syndromes. Premature ejaculation and inorgasmia
- Emotional problems: inappropriate fits of anger and rage, timidness,
passivity, bipolar disorder, frequent infatuation, addictions,
depression, dark mood, obsession, psychotic behaviour, deviant
behaviour, psychic attacks, inability to connect with god, etc.
- Mental problems: memory loss, thinking disorder, messy syndrome
(cluttering), loss of intelligence, AD, premature aging
- GI problems: candida, food allergy, leaky gut syndrome, parasites,
inflammatory bowel disease
- Orthopedic problems: joint arthritis, persisiting musculo-skeletal
pain, fibromyalgia, TMD, recurrent osteopathic lesions
- Immunological disorders (autoimmune diseases, hypothyroid disorders,
MS, ALS, Sjogen´s Syndrome, CFIDS, MCS etc.)
- Cardiovascular disorders ( vascular disease, arrythmias, angina,
increased heartbeat)
- Cancer -mercury, arsenic, copper etc. can be a trigger " ENT
disorders: chronic sinusitis, tinnitus, glandular swelling,
- Eye problems: macular degeneration (dry and wet), optic neuritis,
iritis, deteriorating eye sight, etc.)
- Internal medicine problems: kidney disease, hypertension, hypercholesterinemia,
syndrome X
- OB/gyn: difficulties of pregnancy, impotence, uterine fibroids,
infertility, etc.
C: Diagnosis:
- History of Exposure: (Did you ever have any amalgam fillings?
How much fish do you eat and what kind? A tick bite? etc)
- Symptoms: (How is your short term memory? Do you have areas
of numbness, strange sensations,etc) - A complete neurotoxin questionaire
is available from AANT@425 462 1777
- Laboratory Testing: direct tests for metals: hair, stool, serum,
whole blood, urine analysis, breath analysis
- xenobiotics: fatty tissue biopsy, urine, breath analysis
- Indirect tests: cholesterol (increased while body is dealing
with Hg), increased insulin sensitivity, creatinine clearance,
serum mineral levels (distorted, while Hg is an unresolved issue),
Apolipoprotein E 2/4, urine dip stick test: low specific gravity
(reflects inability of kidneys to concentrate urine), persistently
low urine ph (metals only go into solution in acidic environments
- which supports detoxing), urine porphyrins
- Autonomic Response Testing: (Dr. Dietrich Klinghardt M.D.,
Ph.D.)
- BioEnergetic Testing (EAV, kinesiology etc.)
- Response to Therapeutic Trial
- Functional Acuity Contrast Test (measure of Retinal Blood Flow)
- Non-specific neurological tests: upper motor neuron signs (clonus,
Babinski, hyperreflexia), abnormal nerve conduction studies, EMG
etc . non-specific MRI/CT findings: brain atrophy as in AD, demyelination
- Several 'challenge tests' are used today. They generally
involve measuring the urine metal content, then administering
an oral or iv. mobilizing agent and re-mesuring the metal content
in the urine after a few hours. Most well known is the DMPS challenge
test: However, there is agreement amongst most researchers, that
the urine Hg content does not reflect total body burdon - only
the currently mobilizable portion of Hg in the endothelium and
kidneys. If nothing comes out, there can still be detrimental
but non-responsive amounts of Hg in the CNS, connective tissue
and elsewhere.
- I have developed a simple approach that works well. I use autonomic
response testing (muscle biofeedback) to determine what metal
is stored where and what detox agents would be most suitable for
this individual. I obtain a hair sample and have it analyzed.
It may or may not show any toxic metals. Metals reach the root
of the hair via the blood stream. Hair only can show those metals,
that have been in the blood in the last 6 weeks. That means, hair
only reflects acute toxicity or recently mobilized metals but
not the true body burdon. Then we embark on the detox and mobilizing
program. In 6 weeks another hair samle is send to the lab and
analyzed. If for example manganese is now high, mercury starting
to rise (mostly it is methyl Hg, that is reflected in hair), aluminum
is at the same value as before, it means, that this program is
starting to mobilize Mn ad Hg, but not Al. Through minor adjustments
and following the client closely, we observe as the levels in
the hair may rise for months or years before returning to low
or absent levels. That is the end point. At that time biochemical
challenges with Ca EDTA, DMPS or DMSA can be valuabe to see if
there are still hidden pockets of metals somewhere in the system
that have been ovrlooked with the other methods. In general, the
hair-mineral analysis is often overinterpreted. Hair minerals
are a reflection of the toxic-metal induced distortion in mineral
metabolism.
D. Treatment:
Why would we want to treat anyone at all? Is
it really needed? Can the body not eliminate these toxins naturally
on its own?
First we need to consider a multitude of risk
factors, which influence later decisions: Here is a short list of
independent risk factors which can either cause accumulation of
metals in an otherwise healthy body - or slow down, or inhibit the
bodys own elimination processes.
- Genetics - Several genes are involved in coding for the production
of inherent detox mechanisms. Example: ApoE being the major repair
protein in neuronal damage and responsible for removing mercury
from the intracellular environment. There are 4 different subtypes,
one of them making the individual prone to accumulating Hg: (Danik,
M. and Poirier, J. Apolipoprotein E and lipid mobilizatin in neuronal
membrane remodeling and its relevance to Alzheimer's disease.
In: Brain Lipids and Disorders in Biological Psychiatry, edited
by Skinner, E.R.Amsterdam:Elsevier Science, 2002, p.53-66).
Also well known and studied are the individual genetic differences
in glutathione availability. Several companies in the Integrative
Medicine Field are offering genetic testing today. So far my clinical
results were not impressive when I based my detox program on genetic
testing only.
- Prior illnesses (i.e. kidney infections, hepatitis, tonsillitis
etc.)
- Surgical operations (scars often restrict the detoxifying abilities
of whole body sections, such as the tonsillectomy scar with it´s
effect on the superior cervical ganglion - restricting lymph drainage
and blood flow from the entire cranium)
- Medication or ´recreational´ drug use (overwhelming the
innate detox mechanisms)
- Emotional trauma, especially in early childhood. This issue
is huge and almost never appropriately adressed
- Social status (poor people may still drink contaminated water)
- High carbohydrate intake combined with protein malnutrition
(especially in vegetarians)
- Use of homeopathic mercury (may redistribute Hg into deeper
tissues)
- Food allergies (may block the kidneys, colon etc.)
- The patient's electromagnetic environment (mobile phone use,
home close to power lines etc. Omura showed that heavy metals
in the brain act as micro antennae concentrating damaging electro
smog in the brain)
- Constipation
- Compromise of head/neck lymphatic drainage (sinusitis, tonsil
ectomy scars, poor dental occusion)
- Number of dental amalgam fillings over the patients life-time,
number of the patients mothers amalgam fillings
Detox Methods
There are many considerations in choosing detox agents. After choosing
the appropriate agent for the individual client and particular metal
and exact chemical form of it, we have to consider the body compartment
where the metal is stored. For example, the algae chlorella is ideal
for removing virtually all toxic metals from the gut but has too
little effect on mercury stored in the brain. Intravenous glutathione
may reach the intracellular environment, even in the brain, but
is fairly ineffective in removing mercury from the gut. Each agent
has a primary place of action, which determines when, how much and
for how long it is used. Agents that have multiple effects on compounds
of different metals in the various body compartments are the basis
for our detox program. Most specific agents are used for special
situations only.
High protein, mineral, fatty acid
and fluid intake
Rationale:
- proteins provide the important precursors to the endogenous
metal detox and shuttle agents, such as coeruloplasmin, metallothioneine,
glutathione and others. The branched-chain amino acids in cow
and goat whey have valuable independent detox effects. Amino acid
supplements, especially with a concentrate of brached chain amino
acids are valuable.
- Metals attach themselves only in places that are programmed
for attachment of metal ions. Mineral deficiency provides the
opportunity for toxic metals to attach themselves to vacant binding
sites. A healthy mineral base is a prerequisite for all metal
detox attempts (selenium, zinc, manganese, germanium, molybdenum
etc.). Substituting minerals can detoxify the body by itself.
Just as important are electrolytes (sodium, potassium, calcium,
magnesium), which help to transport toxic waste across the extracellular
space towards the lymphatic and venous vessels.
- Lipids (made from fatty acids) make up 60-80 % of the central
nervous system and need to be constantly replenished. Deficiency
makes the nervous system vulnerabe to the fat soluble metals,
such as metallic mercury constantly escaping as odorless and invisible
vapour from the dental amalgam fillings.
- Without enough fluid intake the kidneys may become contaminated
with metals. The basal membranes swell up and the kidneys can
no longer efficiently filtrate toxins. Adding a balanced electrolyte
solution in small amounts to water helps to restore intra-and
extracellular fluid balance
Pharmaceuticals
- DMSA: developed in China in the late 50s. Action via
sulfhydryl group. Needs to be given every 4 hours around the clock
to prevent redistribution of Hg and lead into the CNS. Approved
for use in lead toxixcity. Causes major brain fog, memory problems
during detox, depression and in children sometimes seizure disorders
due to redistribution of metals. Indiscriminate use in the US.
Common dose: 50-100 mg q4h - 3 days on, 11 days off for 3-12 months
- DMPS: developed in Russia as further development of
BAL. Available both injectable and oral. The oral form is the
most effective oral chelator commercially available. 1 tabl TID.
Common dosage: 3 days on, 11 days off. The injectable form can
be used to mobilize Hg and lead from hard to reach places, such
as the autonomic ganglia, joints and trigger points. The iv injection
works primarily on the endothelium (several hundred square meters)
and the kidneys. Common dosage: 3 mg/kg body weight once/month.
The iv form should never be used unless the patient is "covered"
with intestinal binding agents such as chlorella, cholestyramine,
apple pectin or chitosan.
- Desferal: good subcutaneous detox agent for aluminum
and iron. More severe possible anaphylactic reactions then with
other common detox agents. Research by Canadian-German researcher
Kruck showed good results with AD patients. Dosage: 1 vial/week
s.c - 3 weeks on, 3 weeks off
- Ca EDTA: most information available at www.gordonresearch.com.
Given as 1 minute push 5-10 ml once/week. Originally developped
to remove s calcium deposits, recently found to also be effective
for mercury and other metals including aluminum. Side effects
are so far underreported and can be serious - mostly due to redistribution.
The more conventional use of sodium EDTA over a 2 hr period was
used to increase nitric oxide in the arteries causing vasodilation
and increased perfusion of diseased heart muscle.
- Intravenous Vitamin C: recent book by Tom Levy, MD.
Detoxes mercury, lead and aluminum mostly over the colon which
is desirable. I use 37.5 gms with 500 ml distilled water and 10
ml ca gluconate over 1 hr. Can be used daily. Once a week is common,
especially during amalgam removal. Irritating to veins. Causes
hypoglycemia. No serious side effects. Safe to use for most dentists.Oral
vitamin C works less effectively. Must be given to bowel tolerance.
Natural Oral Agents
Cilantro (chinese parsley)
This kitchen herb is capable of mobilizing mercury, cadmium, lead
and aluminum in both bones and the central nervous system. It is
probably the only effective agent in mobilizing mercury stored in
the inracellular space (attached to mitochondria, tubulin, liposomes
etc) and in the nucleus of the cell (reversing DNA damage of mercury).
Because cilantro mobilizes more toxins then it can carry out of
the body, it may flood the connective tissue (where the nerves reside)
with metals, that were previously stored in safer hiding places.
This process is called re-toxification. It can easily be avoided
by simultaneously giving an intestinal toxin-absorbing agent. A
recent animal study demonstrated rapid removal of aluminum and lead
from the brain and skeleton superior to any known other detox agent.
Even while the animal was continuously poisoned with aluminum, the
bone content of aluminum continued to drop during the observation
period significantly.
Dosage and application of cilantro tincture: give 2 drops
2 times /day in hot water in the beginning, taken just before a
meal or 30 minutes after taking chlorella (cilantro causes the gallbadder
to dump bile - containing the excreted neurotoxins - into the small
intestine. The bile-release occurs naturally as we are eating and
is much enhanced by cilantro. If no chlorella is taken, most neurotoxins
are reabsorbed on the way down the small intestine by the abundant
nerve endings of the enteric nervous system). Gradually increase
dose to 10 drops 3 times/day for full benefit. During the initial
phase of the detox cilantro should be given 1 week on, 2 -3 weeks
off. Fresh organic Cilantro works best (as much as person can compress
in one hand), when given in hot Miso soup. Miso contains synergistically
acting amino acids.
Other ways of taking cilantro: rub 5 drops twice/day into ankles
for mobilization of metals in all organs, joints and structures
below the diaphragm, and into the wrists for organs, joints and
structures above the diaphragm. The wrists have dense autonomic
innervation (axonal uptake of cilantro) and are crossed by the main
lymphatic channels (lymphatic uptake).
Cilantro tea: use 10 to 20 drops in cup of hot water. Sip slowly.
Clears the brain quickly of many neurotoxins. Good for headaches
and other acute syptoms (joint pains, angina, headache): rub 10
-15 drops into painful area. Often achieves almost instant pain
relief.
Chlorella:
Both C.pyreneidosa (better absorption of toxins,
but harder to digest) and C.vulgaris (higher CGF content - see below,
easier to digest, less metal absorbing capability) are available.
Chlorella has multiple health inducing effects:
- Antiviral (especially effective against the cytomegaly
virus from the herpes family)
- Toxin binding (mucopolysaccharide membrane) all known
toxic metals, environmental toxins such as dioxin and others
- Repairs and activates the bodys detoxification functions:
- Dramatically increases reduced glutathion,
- Sporopollein is as effective as cholestyramin in binding neurotoxins
and more effective in binding toxic metals then any other natural
substance found.
- Various peptides restore coeruloplasmin and metallothioneine,
- Lipids (12.4 %) alpha-and gamma-linoleic acid help to balance
the increased intake of fish oil during our detox program and
are necessary for a multitude of functions, including formation
of ther peroxisomes.
- Methyl-coblolamine is food for the nervous system, restores
damaged neurons and has ist own detoxifying efect.
- Chlorella growth factor helps the body detoxify itself in a
yet not understood profound way. It appears that over millions
of years chlorella has developed specific detoxifying proteins
and peptides for every existing toxic metal.
- The porphyrins in chlorophyl have their own strong metal binding
effect. Chlorophyll also activates the PPAR-receptor on the nucleus
of the cell which is responsible for the transcription of Dna
and coding the formation of the peroxisomes (see fish oil), opening
of the cell wall (unknown mechanism) which is necessary for all
detox procedures, normalizes insulin resistance and much more.
Medical drugs that activate the PPAR receptor (such as pioglitazone)
have been effective in the treatment of breast and prostate cancer.
- Super nutrient: 50-60% aminoacid content, ideal
nutrient for vegetarians, methylcobolamin - the most easily absorbed
and utilized form of B12, B6, minerals, chlorophyll, beta carotene
etc.
- Immune system strengthening
- Restores bowel flora
- Digestive aid (bulking agent)
- Alkalinizing agent (important for patients with malignancies)
Dosage: start with 1 gram (=4 tabl) 3-4 times/day.
This is the standard maintainance dosage for grown ups for the 6-24
months of active detox. During the more active phase of the detox
(every 2-4 weeks for 1 week), whenever cilantro is given, the dose
can be increased to 3 grams 3-4 times per day (1 week on, 2-4 weeks
back down to the maintainance dosage). Take 30 minutes before the
main meals and at bedtime. This way chlorella is exactly in that
portion of the small intestine where the bile squirts into the gut
at the beginning of the meal, carrying with it toxic metals and
other toxic waste. These are bound by the chlorella cell wall and
carried out via the digestive tract. When amalgam fillings are removed,
the higher dose should be given for 2 days before and 2-5 days after
the procedure (the more fillings are removed, the longer the higher
dose should be given). No cilantro should be given around the time
of dental work. During this time we do not want to moblize deeply
stored metals in addition to the expected new exposure. If you take
Vitamin C during your detox program, take it as far away from Chlorella
as possible (best after meals). Side effects: most side effects
reflect the toxic effect of the mobilized metals which are shuttled
through the organism. This problem is instantly avoided by significantly
increasing the chlorella dosage, not by reducing it, which would
worsen the problem (small chlorella doses mobilize more metals then
are bound in the gut, large chlorella doses bind more toxins then
are mobilized). Some people have problems digesting the cell membrane
of chlorella. The enzyme cellulase resolves this problem. Cellulase
is available in many health food stores in digestive enzyme products.
Taking chlorella together with food also helps in some cases, even
though it is less effective that way. C.vulgaris has a thinner cell
wall and is better toerated by people with digestive problems.
Chlorella growth factor
This is a heat extract from chlorella that concentrates
certain peptides, proteins and other ingredients. The research on
CGF shows that children develop no tooth decay and their dentition
(maxillary-facial development) is near perfect. There are less illnesses
and children grow earlier to a larger size with higher I.Q and are
socially more skilled. There are case reports of patients with dramatic
tumor remissions after taking CGF in higher amounts. In our experience,
CGF makes the detox experience for the patient much easier, shorter
and more effective. Recommended dosage: 1 cap. CGF for each 20 tabl.chlorella
NDF and PCA
Both are extracts from Chlorella and Cilantro
and very effective in detoxing. They are well tolerated, but very
expensive.
Garlic (allium sativum) and wild garlic (allium
ursinum)
Garlic has been shown to protect the white and
red blood cells from oxidative damage, caused by metals in the blood
stream - on their way out - and also has ist own valid detoxification
functions. Garlic contains numerous sulphur components, including
the most valuable sulph-hydryl groups which oxidize mercury, cadmium
and lead and make these metals water soluble. This makes it easy
for the organism to excrete these subastances. Garlic also contains
alliin whis is enzymatically transformed into allicin, natures most
potent antimicrobial agent. Metal toxic patients almost always suffer
from secondary infections, which are often responsible for part
of the symptoms. Garlic also contains the most important mineral
which protects from mercury toxicity, bio active selenium. Most
selemium products are poorly absorbable and do not reach those body
compartments in need for it. Garlic selenium is the most beneficial
natural bioavailable source. Garlic is also protectice for against
heart disease and cancer. The half life of allicin (after crushing
garlic) is less then 14 days. Most commercial garlic products have
no allicin releasing potential left. This distinguishes freeze dried
garlic from all other products. Bear garlic tincture is excellent
for use in detox, but less effective as antimicrobial agent.
Dosage: 1-3 capsules freeze dried garlic after
each meal. Start with 1 capsule after the main meal per day, slowly
increase to the higher dosage. Initially the patient may experience
die-off reactions (from killing pathogenic fungal or bacterial organisms).
Use 5-10 drops bear-garlic on food at least 3 times per day.
Fish oil:
It is clear that the high consumption of fish oil protects the
client from the damage caused by the amalgam fillings. The same
is true for the high intake of selenium. The fatty acid complexes
EPA and DHA in fish oil make the red and white blood cells more
flexible thus improving the microcirculation of the brain, heart
and other tissues. All detoxification functions depend on optimal
oxygen delivery and blood flow. EPA and DHA protect the brain from
viral infections and are needed for the development of intelligence
and eye-sight. They also induce the formation of peroxisomes and
helps protect them. The most vital cell organelle for detoxification
is the peroxisome. These small structures are also responsible for
the specific job each cell has: in the pineal gland the melatonin
is produced in the peroxisome, in the neurons dopamine and norepinephrine,
etc. It is here, where mercury and other toxic metal attach and
disable the cell from doing its work. Other researchers have focussed
on the mitochondria and other cellorganelles, which in our experience
are damaged much later. The cell is constantly trying to make new
peroxisomes to replace the damaged ones- for that task it needs
an abundance of fatty acids, especially EPA and DHA. Until recently
it was believed, that the body can manufacture ist own EPA/DHA from
other Omega 3 fatty acids such as fish oil. Today we know, that
this process is slow and cannot keep up with the enormous demand
for EPA/DHA our systems have in todays toxic environment. Fish oil
is now considered an essential nutrient, even for vegetarians. Recent
research also revealed, that the transformation humans underwent
when apes became intelligent and turned into humans happened only
in coastal regions, where the apes started to consume large amounts
of fish.
The fatty acids in fish oil are very sensitive to exposure to electromagnetic
fields, temperature, light and various aspects of handling and processing.
Trans fatty acids, long chain fatty acids, renegade fats and other
oxydation products and contaminants are frequently found in most
commercial products. Ideally, fish oil should be kept in an uninterrupted
cooling chain until it ends up in the patients fridge. The fish-source
should be mercury and contaminant free, which is becoming harder
and harder. Fish oil should tast slightly fishy but not too much.
If there is no fish taste, too much processing and manipulation
has destroyed the vitality of the oil. If it tastes too fishy, oxydation
products are present. There are 5 commercially available grades
of fish oil. Grade I is the best.
Dosage: 1 capsule Omega 3 taken 4 times/day during
the active phase of treatment, 1 caps. twice/day for maintainance.
Best if taken together with chlorella. Recently a fatty acid receptor
has been discovered on the tongue, joining the other more known
taste receptors. If the capsules are chewed or a liquid oil is taken,
the stomach and pancreas start to prepare the digestive tract in
exactly the right way to prepare for maximum absorption. To treat
bipolar depression, post partum depression and other forms of mental
disease, 2000 mg of EPA are needed/day (David Horrobin). For the
modulation of malignancies, 120 mg of EPA 4 times/day are needed.
The calculations can easily be done with the information given on
the label.
Balanced electolyte solution (Selectrolyte)
The autonomic nervous system in most toxic patients is dysfunctional.
Electric messages in the organism are not received, are misunderstood
or misinterpreted. Toxins cannot be shuttled through the extracellular
space. Increased intake of natural ocean salt (celtic sea salt)
- and avoidance of regular table salt - has been found to be very
effective in resolving some of these problems. Most effective is
a solution pioneered by the American chemist Ketkovsky. He created
the formula for the most effective electrolyte replacement, which
was further improved by Morin Labs, and is now called 'selectrolyte'.
Dosage: 1 tsp in a cup of good water 1-3 times/day During times
of greater stress the dosage can be temporarily increased to 1 tbsp
3 times/day
Adjuvant therapies:
Lymphatic drainage:
Mobilized metals and toxins tend to get stuck
in the connective tissue and lymph channels. They can no longer
be reached by biochemical agents. A mechanical approach is needed.
Dr.Vodder´s MLD approach is very good. We are using a superb group
of microcurrent instruments developed by a Japanese researcher.
The results are often astounding. The device can also be applied
transcranially to mobilize metals from the brain with ease and with
no side effects, when the patient is simultaneously on a good detox
program. I call this process electromobilization.
Photomobilization:
I found that the release of metals from the CNS
can be rapidly achieved with the use of narrow band polarized lightstimulation
of the eyes. Each metal can be defined by it´s spectral emissions
when it is heated up (Fraunhofer lines). When light of the exact
same frequency is beamed into the eye (using a special instrument)
the release of this exact metal from the intracellular environment
into the blood stream is triggered.
Sauna therapy:
Peer reviewed literature shows that sweatting
during sauna therapy eliminates high levels of toxic metals, organic
compounds, dioxin, and other toxins. Sauna therapy is ideal to mobilize
toxins from its hiding places. However, during a sauna, toxic metals
can also be displaced from one body compartment into another. This
means mercury can be shifted from the connective tissue into the
brain. This untoward effect is completely prevented when the patient
is on chlorella, cilantro and garlic. The addition of ozone can
be used to deliver an effective anti-microorganism hit while in
the sauna. The moment mercury and other metals are removed from
the body, microorganisms start to grow. We use a ozone steam cabinet
which allows us to combine the effects of hyperthermia and ozone
therapy in a very safe and comfortable way.
Colon hydrotherapy:
Colon hydrotherapy removes not only fecal matter
from the bowel but also sludge and debris that has attached itself
to the wall of the colon. It has been shown that these residues
can be years even decades old and often leaked out toxic doses of
many different chemicals during those years of residue collection.
During a metal detoxification program, many toxins appear on the
bowel surface and shifted from bowel surface into the fecal matter.
However, since many of the toxins are neurotoxins, and the colon
is lined with nerve endings, many of the mobilized toxins are reabsorbed
into the body on the way down. To intercept these toxins while in
the colon, colon hydrotherapy is the ideal method. Recommended use:
1-2 colonics per week during active phase of detox.
Acupuncture and Neural therapy:
Both are closely related techniques that balance
the autonomic nervous system (ANS). Compartmentalized metals are
often trapped because of specific dysfunctions of the ANS. Both
can be resolved with either technique.
Exercise:
To facilitate in the detoxification process, exercise
is absolutely needed. Many patients with chronic disease are unable
to engage in vigorous exercise e.g. jogging. We help our clients
to find the right level of exercise appropriate to their level of
illness. Without exercise, mobilized toxins accumulate in the connective
tissue, kidneys, lungs and skin and can cause a new set of symptoms
and perpetuate the patient's illness. A good exercise program should
include 3 components: a) muscle strength training b) aerobic training
c) stretching. Recommendations: 20 minutes
twice a day is the minimum requirement during the active detox phase.
Kidney protection:
When metals are mobilized a certain portion travels
through the kidneys. The kidneys may react with swelling of the
basal membranes and decrease in filtration rate. To prevent damage
to the kidneys the patient has to drink increasing amounts of water
(with selectrolyte solution). The kidny has a filtrating surface
equal to a ping-pong table, the gut that of a soccer field. The
nephrons - like brain cells - live long and cannot be replaced once
damaged. The gut membranes are renewed every 3 days. It is foolsih
to push toxic metals through the kidneys and wise, to push them
out through the gut. Chlorella pulls toxic metals through the mucosal
surface of the intestines from the blood and protects the kidneys.
Additional recommended supplement: Renelix 15 drops three times
a day.
Bowel flora:
When metals are moved out of the body through
the feces, the bowel flora is damaged. During the active phase of
the detox, chlorella works as an excellent pre-probiotic: It selectively
feeds the good bowel flora. In addition, we recommend taking HLC
(Acidophilus/Bifidus) two capsules with each meal.
Psychological issues:
There is a strange but largely overlooked association
of metal toxicity and psychological issues. I found that often when
the client has a breakthrough in psychotherapy her/his symptoms
become temporarily worse. This is often falsely believed to be a
healing crisis (immune system acivation). In this situation the
client´s urine will often show high levels of toxic metals with
out a provocative agent being used. The psychological intervention
has led to a release of deeply stored toxins. I developed a targeted
rapid approach to resolve related psychological issues called "applied
psychoneurobiology or APN", which is a form of muscle biofeedback
assisted counseling.
The Klinghardt Axiom and the Triad of Detoxification:
By experience I found the following to be true: each unresolved
psycho-emotional conflict or each unresolved past trauma causes
the body to lose the ability to successfully recognize and excrete
toxic substances. Also each entanglement or limiting connection
with another family member, unhealed relationships and unhealthy,
non-life affirmative attitudes limit the organisms ability to detoxify
itself. In fact, the type of retained metal or other toxin and the
body compartment, where it is stored, can be predicted with a high
degree of certainty by knowing what type of unresolved psycho- emotional
conflict is present in a client and at what age the associated event
occurred.
For each unresolved psychological issue there is an equal
amount of toxins stored in the body.
When the patient starts to effectively detoxify on the physical
level, repressed emotional material moves from the unconscious to
the more superficial subconscious part of the brain. Instead of
feeling better from the lessened toxin burden, the patient will
often start to experience unpleasant inner states of being, e.g.
tension, anxiety, sadness or anger. This is commonly mistaken as
a side-effect of the medications used for detoxification or as an
unspecified "detox reaction". When this emotional material is not
dealt with, the body stops releasing further toxins - the tension
or discrepancy between the unresolved psycho-emotional material
and the already released physical toxins is too large. Both are
out of balance - the toxin container is less full then the container
with the unresolved emotions. Unless appropriate psychological intervention
is chosen as the next step in treatment, detoxification cannot progress.
Things are further complicated by the increased activity of microorganisms
such as fungi and molds, bacteria, viruses, prions and different
species of mycoplasma during a detox program. Insecticides, herbicides,
wood preservatives, mercury, and other toxins are used by us with
a single purpose - to stop the growth of microorganisms and other
unwanted pests in the outside world (farm fields, materials and
furniture made from wood, to preserve food, etc.). When these toxic
agents have entered our inner environment (via the food chain, air,
water, skin contact or amalgam fillings) they have the same effect
in us. They stop the growth of microorganisms - at a price: they
also harm the cells of our body. As the patient is detoxifying from
these agents, microorganisms may grow out of control, since the
growth of the microbes is no longer inhibited by the poison. Paradoxically,
it is the toxin induced impairment of our immune system that enables
the microorganisms to enter our system in the first place. Once
established, they are hard to conquer and removing the causative
toxin is no longer enough. The organism needs help with the elimination
of the infectious agents.
The flare-up of previously hidden infections occurs
regularly during mercury detoxification. Historically, this fact
is well known: mercury was used quite effectively for treatment
of the bacterial spirochete causing syphilis. Some people died from
side effects of the treatment, but many people lived after eradication
of the infection. The reverse happens, when we withdraw mercury
from the body: spirochetes, streptococci and other microorganisms
present in many hiding places (such as the red blood cells, the
jaw bone, inside the lateral canals of a root filled tooth, inside
the calculus of a bone spur, in the soft tissues of a whip-lash
injured neck, in the gray matter of the brain etc.) may start to
grow and extend their hold on us. Microorganisms use their respective
neurotoxins to gradually achieve control over our immune system,
our behavior, our thinking, and every aspect of our biochemistry.
It is the microbial neurotoxins that are responsible for many, if
not most poison related symptoms, not the poisons themselves.
For each equivalent of stored toxins there is an equal amount
of pathogenic microorganisms in the body (Milieu theory of Bechamp)
Patients who are infected with Borrelia burgdorferi, the spirochete
which causes Lyme disease, often are unaware of their illness. They
may have some joint pains or fatigue, but nothing that alarms them.
However, frequently they start to become more symptomatic during
or after a successful mercury detoxification program: they may experience
MS-like symptoms such as muscle weakness, increased levels of pain,
numbness, fatigue or mental decline. The same is true for infections
with mycoplasma, streptococci, tuberculosis and others. Therefore,
it is important to anticipate the temporarily enhanced growth of
microorganisms during a successful detox program. There is a latent
period in which the microorganisms are already recovered, but the
host's immune system is not. During this time the practitioner has
to prescribe appropriate antifungal, antibacterial, antiviral, and
antimycoplasma medications. I prefer natural solutions which are
often sufficient - or even better in the long run then medical drugs
- such as freeze dried garlic, bee propolis, colloidal gold and
microbial inhibition microcurrent frequencies.
The immune system in a client with unresolved psychoemotional material
and compartmentalized toxins is unable to recognize and eliminate
the microorganisms present in the toxic areas of the body. Those
areas serve as hiding and breeding places for these organisms. Unfortunately
they have been termed "stealth organisms", implying that they behave
in secret unpredictable ways, that they have learned to evade a
perfectly evolved and functional immune sytem. There is a fear,
that they are slowly gaining control over us and that there is really
nothing we can do about it. We can, if we understand the triad of
detoxification.
The Detoxification Axiom: For each unresolved psycho-emotional
conflict or trauma there is an equivalent of stored toxins and an
equivalent of pathogenic microorganisms. To successfully detoxify
the body the three issues have to be addressed simultaneously.
The triad of detoxification:
- Detoxification of the physical body
- Treatment of latent microorganisms and parasites
- Treatment of unresolved psycho-emotional issues
E. Conclusion:
Detoxing the patient from heavy metals can be
an elegant smooth experience or rollercoaster ride. The problems
that occur can always be resolved with the use of autonomic response
testing (ART). Without the use of ART and addressing the psychological
issues (with APN), embarking on a heavy metal detox program can
be unsatisfying, incomplete, sometimes dangerous and may not lead
to resolution of the underlying medical condition. We recommend
that each patient undergoing a metal detox program stays under the
supervision of an experienced and qualified practitioner. There
are many more ways to approach metal detox. However, many roads
I have witnessed also did not lead to complete resolution of the
underlying problem and are shortsighted. The practitioner should
avoid short term interventions for long term issues and should not
underestimate the depth and magnitude of the underlying problem.
F. References:
and recommended reading about mercury from dental fillings and
related issues.
The references for chlorella, CGF, Fish oil, cilantro, garlic,
ART, APN and others can be obtained from the American Academy of
Neural Therapy: aant@neuraltherapy.com
and at www.neuraltherapy.com
|
|
1
|
Carlson,
J., Larsen, J.T., and Edlund, M.-B.: Peptostreptococcus
micros has a uniquely high capacity to form hydrogen sulfide
from glutathione. Oral Microbiol. Immunol., 8:
42-45, 1993 |
|
2
|
Debelian,
G.J., Olsen, I., and Tronstad, L.: Systemic diseases caused
by oral microorganisms. Endod. Dent. Traumatol.,
10: 57-65, 1994 |
|
3
|
De Boever,
E.H., De Uzeda, M., and Loesche, W.J.: Relationship between
volatile sulfur compounds, BANA-hydrolyzing bacteria and
gingival health in patients with and without complaints
of moral malodour. J. Clin. Dent.,4: 114-119, 1994
|
|
4
|
Duhr, E.F.,
Pendergrass, J.C., Slevin, J.T., and Haley, B.E.: HgEDTA
complex inhibits GTP interactions with the E-site of the
brain ß-tubulin. Toxicol. Appl. Pharmacol., 122:
273-280, 1993 |
|
5
|
Giuliana, G., Ammatuna, P., Pizzo,
G., Capone, F., and D'Angelo, M.: Occurrence of invading
bacteria in radicular dentin of periodontally diseased
teeth: microbiological findings. J. Clin. Periodonto.,
24: 478-485, 1997 |
|
6
|
Granlundt-Edstedt, M., Johannson,
E., Claesson, R., and Carlsson, J.: Effect of anaerobiosis
and sulfide on killing of bacteria by polymorphonuclear
leukocytes. J. Periodont. Res., 8: 346-353, 1993 |
|
7
|
Hannah, R.S., Hayden, L.J., and Roth,
S.H.: Hydrogen sulfide exposure alters the amino acid
content in developing rat CNS. Neurosci. Lett.,
99: 323-327, 1989 |
|
8
|
Johnson, P.W., Yaegaki, K., and Tonzetich,
J.: Effect of volatile thiol compounds on protein metabolism
by human gingival fibroblasts. J. Periodont. Res.,
27: 553-561, 1992 |
|
9
|
Khatoon, S., Campbell, S.R., Haley,
B.E., and Slevin, J.T.: Aberrant guanosine triphosphate-ß-tubulin
interaction in Alzheimer's disease. Ann. Neurol.,
26: 210-215, 1989 |
|
10
|
Kilburn, K.H., and Warshaw, R.H.:
Hydrogen sulfide and reduced-sulphur gases adversely affect
neurophysiological functions. Toxicol. Ind. Health,
11: 185-197, 1995 |
|
11
|
Kombian, S.B., Reiffenstein, R.J,
and Colmers, W.F.: The actions of hydrogen sulfide on
dorsal raphe serotonergic neurons in vitro. J. Neurophysiol.
81-96, 1993 |
|
12
|
Larsen, J.T., Claesson, R., Edlund,
M.-B. and Carlsson, J.:Competition for peptides and amino
acids among periodontal bacteria. J. Periodont. Res.,30:
390-395, 1995 |
|
13
|
Loomer, P.M., Sigusch, B., Sukhu,
B., Ellen, R.P. and Tenenbaum, H.C.: Direct effects of
metabolic products and sonicated extracts of Porphyromonas
gingivalis 2561 on osteogenesis in vitro. Infect. Immun.,
62: 1289-1297, 1994 |
|
14
|
Nair, P.N:R., Sjogren, U., Krey,
G., Kahnberg, K.-E., Sundqvist, G.: Intraradicular bacteria
and fungi in root-filled, asymptomatic human teeth with
therapy-resistant periapical lesions: a long-term light
and electron microscopic follow-up study. J. Endodon.16:
580-588, 1990 |
|
15
|
Pendergrass, J.C., Haley, B.E., Vimy,
M.J., Winfield, S.A., and Lorscheider, F.L.: Mercury vapor
inhalation inhibits binding of GTP to tubulin in rat brain:
similarity to a molecular lesion in Alzheimer diseased
brain. Neurotoxicology, 18: 315-324, 1996 |
|
16
|
Pendergrass, J.C., Haley, B.E.:
Inhibition of brain tubulin-guanosine 5'-triphosphate
interactions by mercury: Similarity to Observations in
Alzheimer's diseased brain. Metal ions in biological
systems: mercury and its effects on environment and biology
(Sigel, H. and Sigel, A., eds) Marcel Dekker, Inc., New
York, pp461-478, 1996 |
|
17
|
Pendergrass, J.C., Haley, B.E.: Mercury-EDTA
complex specifically blocks brain ß-tubulin interactions:
similarity to observations in Alzheimer's disease. Status
quo and perspectives of amalgam and other dental materials
(Friberg L.T. and Schrauzer G.N., eds) Georg Thieme Verlag,
Stuttgart, pp98-105, 1995 |
|
18
|
Persson, S.: Hydrogen sulfide and
methyl mercaptan in periodontal pockets. Oral Microbiol.
Immunol., 7: 378-379, 1992 |
|
19
|
Persson, S., Claesson, R., Carlsson,
J.: Chemotaxis and degranulation of polymorphonuclear
leukocytes in the presence of sulfide. Oral Microbiol.
Immunol., 8: 46-49, 1993 |
|
20
|
Ratcliff, P.: Local predisposing
events leading to gingivitis and periodontitis. J.
Periodont., 66: 749-750, 1995 |
|
21
|
Reiffenstein, R.J., Hulbert, W.C.,
and Roth, S.H.: Toxicology of hydrogen sulfide. Annu.
Rev. Pharmacol. Toxicol. 109-134, 1992 |
|
22
|
Roth, S.H., Skrajny, B., and Reiffenstein,
R.J.: Alterations of the morphology and neurochemistry
of the developing mammalian nervous system by hydrogen
sulfide. Clin. Exptl. Pharmacol. Physiol.379-380,
1995 |
|
23
|
Skrajny, B., Reiffenstein, R.J. Sainsbury,
R.S., and Roth, S.H.: Effects of repeated exposures of
hydrogen sulphide on rat hippocampal EEG. Toxicol.
Lett., 84: 43-53, 1996 |
|
24
|
Warenycia, M.W., Goodwin, L.R., Benishin,
C.G., Reiffenstein, R.J., et al.: Acute hydrogen sulfide
poisoning. Biochem. Pharmacol., 38: 973-981, 1989 |
|
25
|
Safavi, K.E., Rossomando, E.F.: Tumor
necrosis factor identified in periapical tissue exudates
of teeth with apical periodontitis. J. of Endodontitis,
17(1): 12ff, 1990 |
|
26
|
Maiorino, R.M., et al.:Sodium 2,3-dimercaptopropane-1-sulfonate
challenge test for mercury in humans. III. Urinary mercury
after exposure to mercurous chloride. J. Pharmacol.
Exp. Ther., 277(2): 938-44, 1996 |
|
27
|
Keith, R.L., et al.: Utilization
of renal slices to evaluate the efficacy of chelating
agents for removing mercury from the kidney. Toxicology,
116(1-3): 67-75, 1997 |
|
28
|
Aposhian, M.M., et al.: Sodium 2,3-dimercapto-1-propanesulfonate
(DMPS) treatment does not redistribute lead or mercuri
to the brain of rat. Toxicology, 109(1): 49-55,
1996 |
|
29
|
Aposhian, H.V., et al.: Urinary
mercury after administration of 2,3-dimercaptopropane-1-sulfonic
acid: correlation with dental amalgam score. FASEB
J., 6(7): 2472-6, 1992 |
|
30
|
Aposhian, H.V., et al.: Human studies
with the chelating agents, DMPS and DMSA. J. Toxicol.
Clin. Toxicol., 30(4): 505-28, 1992 |
|
31
|
Hermann, M., Schweinsberg, F.: Biomonitoring
for the evaluation of a mercury burden from amalgam fillings.
Mercury determination in urine before and after oral doses
of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and in
hair. Abteilung Allgemeine Hygiene und Umwelthygiene,
Universität Tübingen, Zentralbl-Hyg-Umweltmed., 194(3):
271-91, 1993 |
|
32
|
Zander, D., et al.: The mercury exposure
of the population. III. Mercury mobilisation by DMPS (Dimaval)
in subjects with and without amalgam fillings. Medizinisches
Institut für Umwelthygiene, Heinrich Heine-Universität
Düsseldorf |
|
33
|
Molin, M., et al.; Mobilized mercury
in subjects with varying exposure to elemental mercury
vapour. Int. Arch. Occup. Environ. Health, 63(3):
187-92, 1991 |
|
34
|
Maiorino, R.M., et al.: Determination
and metabolism of dithiol chelating agents. XII Metabolism
and pharmakinetics of sodium 2,3-dimercapto-1-sulfonate
in humans. J. Pharmacol. Exp. Ther., 259(2): 808-14,
1991 |
|
35
|
Gerhard, I., et al.: Diagnosis of
heavy metal loading by the oral DMPS and chewing gum tests.
Clin. Lab., 38: 404-11, |
|
36
|
Gonzales-Ramirez, D., et al.: Urinary
mercury, porphyrins and neurobehavioral changes in dental
workers in Monterrey, Mexico. J. Pharmacol. Exp. Therap.,
272: 264-274, 1995 |
|
37
|
Godfrey, M. and Campbell N.: Confirmation
of mercury retention and toxicity using (DMPS). J.
Advance Med., 7(1): 19-30, 1994 |
|
38
|
WHO Criteria 118, 1991 |
|
39
|
Konetzka, W.: Microbiology of metal
transformation, microorganisms and minerals, 317-342,
1977 |
|
40
|
Lexmond, T.-M., et al.: On the methylation
of inorganic mercury and the decomposition of organo-mercury
compounds - A review. Neth. J. Aci., 24: 79-97,
1976 |
|
41
|
Compeau, G. and Bartha, R.: Methylation
and demethylation of mercury under controlled redox, pH
and salinity conditions. Appl. & Environ. Microbio.
Vol. 48, No. 6, 1203-1207, 1984 |
|
42
|
Edwards, T.: Biosyntheses and degradation
of methyl mercury in human faeces. Nature, Vol.
253, 462-464, 1975 |
|
43
|
Blum, J. and Bartha, R.: Effect of
salinity on Methylation of mercury. Bulletin Environ.
Contam. Toxicol., 25: 404-408, 1980 |
|
44
|
Bertilson, L. and Neujahr, H.Y.:
Methylation of mercury compounds by methylcobalamin. Biochemistry,
Vol. 10, No. 14, 2805-2828, 1971 |
|
45
|
Imura, N., et al.: Chemical Methylation
of inorganic mercury with methylcobalamin, a vitamin B-12
analog. Science, Vol. 172, 1248-1249, 1971 |
|
46
|
Jernelov, A. and Martin, A.: Ecological
implications of methal metabolism by microorganisms. Annual
Review of Microbiology, 61-77, 1975 |
|
47
|
Lander, L.: Biochemical model for
the biological Methylation of mercury suggested from Methylation
studies in vivo with Neurospora crassa. Nature,
Vol. 230, 452-454, 1971 |
|
48
|
Wataha et al.: Dental Materials.
10(5): pp2988-303, 1994 |
|
49
|
Hamdy, M.K., and Noyes, O.R.: Formation
of methyl mercury by bacteria. Appl. Microbiol.,
Vol. 30, No. 3, 424-432, 1975 |
|
50
|
Brunker, R.L. and Bott, T.L.: Reduction
of mercury to the elemental state by a yeast. Appl.
Microbiol., Vol 27, No. 5, 870-73, 1974 |
|
51
|
Holm, H.W. and Cox, M.F.: Transformation
of elemental mercury by bacteria. Appl. Microbiol.,
Vol. 29, No. 4, 491&494, 1975 |
|
52
|
Pan Hou, H.S. and Imura, N.: Involvement
of mercury Methylation in Microbial mercury detoxification.
Arch. Microbiol., 131: 176-177, 1982 |
|
53
|
Bisogni, J.J. and Lawrence, A.W.:
Kinetics of mercury Methylation in aerobic and anaerobic
aquatic environments. J. Water Pollut. Control Fed.,
47: 135-152, 1975 |
|
54
|
Report on the international committee
on MAC values on mercury (1969) |
|
55
|
USEPA document on mercury 1973 &
1984 |
|
56
|
US NIOSH document on mercury 1973 |
|
57
|
Wieliczka, D.M. et al.: Equilibrium
vapor pressure of mercury from dental amalgam in vitro.
Dent. Mater., 12(3): 179-184, 1996 |
|
58
|
Bjorkman, L. and Lind, B.: Factors
influencing mercury evaporation from dental amalgam fillings.
Scand. J. Dent. Res., 100(6) 354-60, 1992 |
|
59
|
Lussi, A.: Mercury release from amalgam
into saliva: An in-vitro study. Schweiz. Monatsschr.
Zahnmed. 103(6): 722-6, 1993 |
|
60
|
Olson, S. and Bergman, M.: Daily
dose calculations from measurements of intra-oral mercury
vapor. J. Dent. Res., 71(2): 414-23, 1992 |
|
61
|
Vimy, M.J. and Lorscheider, F.L.:
Dental amalgam mercury daily dose estimated from intra-oral
vapor measurements: A predictor of mercury accumulation
in human tissues. The Journal of trace elements in
experimental medicine, 3(1): 11-123, 1990 |
|
62
|
Emler and Cardone: An assessment
of mercury in mouth air. Oral Roberts University,
March 1985 |
|
63
|
Vimy, M.J. and Lorscheider, F.L.:
Serial measurements of intra-oral air mercury: estimation
of daily dose from dental amalgam. J. Dent. Res.64(8):
1072-5, 1985 |
|
64
|
Abraham, J. et al.: The effect of
dental amalgam restorations on blood mercury levels. J.
Dent. Res., 63(1): 71 & 73, 1984 |
|
65
|
Ott, K. et al.: Mercury burden due
to amalgam fillings. Dtsch. Zahnärztl. Zeitung,
39(9): 199-205, 1984 |
|
66
|
Svare, C.W. et al.: The effects of
dental amalgam on mercury levels in expired air. J.
Dent. Res.,60(9): 1668-1671, 1981 |
|
67
|
Stortebecker, P.: Mercury poisoning
from dental amalgam |
|
68
|
Schubert, J.: Combined effects in
toxicology - A rapid systematic testing procedure cadmium,
mercury and lead. J. Toxic. Envir. Health, 4: 763-776,
1978 |
|
69
|
Fedin, B.: Swed. Dent. J.
3: 8-15, 1988 |
|
70
|
Pendergrass, et al.: Neurotoxicology.
18(2): 315-324, 1997 |
|
71
|
Hanson, M.: J. Orthomol. Psychatry,
Vol 12, No. 3, 1983 |
|
72
|
Vimy, M.J. and Lorscheider, F.L.J.:
Dent. Res., 64: 1069-71, 1985 |
|
73
|
Berglund, A. et al.: Determination
of the rate of release of intra-oral mercury vapor from
amalgam. J. Dent. Res., 67: 1235-242, 1988 |
|
74
|
Grandjean, P. et al.: Cognitive deficit
in 7-year-old children with prenatal exposure to methylmercury.
Neurotoxicol. Teratol., 19(6): 417-28, 1997 |
|
75
|
Marlowe et al.: Low mercury levels
and childhood intelligence. J. of orthomol. Medicine,
Vol 1, No. 1, 1986 |
|
76
|
Reinhardt, J.W.: Side-effects: mercury
contribution to body burden from dental amalgam. Adv.
Dent. Res. 6:110-3, 1992 |
|
77
|
Vanherle, G.: Dental care using silver
amalgam. Verh. K. Acad. Belg., 58(5): 587-634,
1996 |
|
78
|
Danscher, G. et al.: Traces of mercury
in organs from primates with amalgam fillings. Department
of Neurobiol. Univers. Of Aarhus, Denmark, Exp-Mol-Pathol.,
52(3):219-9, 1990 |
|
79
|
Weiner, J.A. et al.: Does mercury
from amalgam restorations constitute a health hazard?
AU: AD: National Board of occupat. Safety and Health,
Solna, Sweden, Sci-Total-Environ. 99(1-2): 1-22, 1990 |
|
80
|
Drasch, G. et al.: Eur. J. Pediatr.,
153(8): 607-10, 1994 |
|
81
|
Arvidson, B.: Inorganic mercury is
transported from muscular nerve terminals to spinal and
brainstem motoneurons. Muscle Nerve, 15(10): 1089-1094,
1992 |
|
82
|
Retrograde axonal transport of mercury
in primary sensory neurons innervating the tooth pulp
in the rat. Neurosci. Lett. 115(1): 29-32, 1990 |
|
83
|
Aschner: Effects of systemic methyl
mercury-adulerated water consumption on fast axonal transport
in the rat visual system. Acta Pharmacol. Toxicol.
(Copenh.), 59(5): 349-55, 1986 |
|
84
|
Lorscheider, F.L. et al.: FASEB
J. 9(4): A-3845. FASEB Annual Meeting, Atlanta, Georgia,
10th March 1995 |
|
85
|
Szucs, A. et al.: Effects of inorganic
mercury and methymercury on the ionic currents of cultured
rat hippocampal neurons. Cell. Mol. Neurobiol.,
17(3): 273-88, 1997 |
|
86
|
Goering et al.: Fundam. Appl.
Toxicol., 19: 319-329, 1992 |
|
87
|
Pendergrass, J.C. et al.: Mercury
Vapor inhalation inhibits binding of GTP to tubulin in
rat brain: Similarity to a molecular lesion in Alzheimer
diseased brain. Neurotoxicology, in press, 1997 |
|
88
|
Haley, B.E. et al.: FASEB J. 9(4):
A-3845. FASEB Annual Meeting, Atlanta, Georgia, 10th
March 1995 |
|
89
|
Duhr, E. et al.: Federations of
American Societies for experimental biology (FASEB). 75th
Annual Meeting, Atlanta, Georgia. 21.-25 April 1991. Abstract
493. Hg2+ induces GTP-tubulin interactions in rat brain
similar to those observed in Alzheimer's disease. |
|
90
|
Pamphlett, R. and Waley, P.: Motor
neurons uptake of low dose inorganic mercury. J. Neurol.
Sci., 135(1): 63-7, 1996 9 |
|
91
|
1 Oskarsson, A., et al.: Total and
inorganic mercury in breast milk in relation to fish consumption
and amalgam in lactating women. Arch. Environ. Health,
51(3): 234-41, 1996 |
|
92
|
Amin.Zaki, L., et al.: Methyl mercury
poisoning in the Iraqi suckling infant: A longitudinal
study over five years. J. Appl. Toxicol., 1(4):
2104, 1981 |
|
93
|
Redhe, O.: Pleva recovery from amyotrophic
lateral sclerosis and from allergy after removal of dental
amalgam fillings. J. Int. J. Risk Safety Medicine,
4: 229-236, 1994 |
|
94
|
Enwonwu, C.O.: Potential health hazard
of the use of mercury in dentistry: Critical review of
the literature. Environ. Res., 42: 257-274, 1987 |
|
95
|
Guinta, F. et al.: Severe acute poisoning
from the ingestion of a permanent ware solution of mercuric
chloride. Hum. Toxicol., 2: 243-246, 1983 |
|
96
|
Rosenmann, K.D., et al.: Sensitive
indicators of inorganic mercury toxicity. Arch. Environ.
Health, 41: 208-215, 1986 |
|
97
|
Desi, I., et al.: Effect of subchronic
mercury exposure on electrocorticogram of rats. Neurotoxicology.
17(3-4): 719, 23, 1996 |
|
98
|
Angotzi, G., et al.: Impairment of
nervous system in workers exposed to inorganic mercury.
Toxicol. Eur. Res., 3(6): 275-8, 1981 |
|
99
|
Marriott, J.B., Quasim: Anti-phospholipid
antibodies in the mercuric chloride treated brown Norway
rat. J. Autoimmun., 4:457:67, 1994 |
|
100
|
Shapiro, et al. and Ship II, et al.:
Reported the relation between cumulative exposure to mercury
and chronic health impairment |
|
101
|
Cutright, D.E., et al.: Systemic
mercury levels caused by inhaling mist during high-speed
amalgam grinding. J. Oral Med., 28, 100, 1973 |
|
102
|
Cross et al.: Blood of dentists.
Lancet, 312, 1978 |
|
103
|
Ngim, C.H., et al.: Chronic neurobehavioral
effects of elemental mercury in dentists. British Journal
of Industrial Medicine, 49: 782-790, 1992 |
|
104
|
Foo, S.C., et al.: Neurobehavioral
effects in occupational chemical exposure. Environ.
Res., 60(2): 267-73, 1993 |
|
105
|
Uzzell, B.P., et al.: Chronic low-level
mercury exposure and neuropsychological functioning. J.
Clin. Exp. Neuropsych., 8(5): 581-593, 1986 |
|
106
|
Shapiro, I.M. et al.: Neurophysiological
and neuropsychological function in mercury exposed dentists.
Lancet, 1(8282): 1147-1150, 1982 |
|
107
|
Echeverria, D. et al.: Behavioral
effects of low-level exposure to Hg among dentists. Neurotoxicology
and Teratology, 17(2): 161-168, 1995 |
|
108
|
Ritchie, K.A. et al.: Psychomotor
testing of dentists with chronic low-level mercury exposure.
J. Dent. Res., 74(S1): 420, A-160 |
|
109
|
Drasch et al.: Trace elements in
medicine and biology. 9(2):82-7, 1995 |
|
110
|
Hahn, L.J., et al.: FASEB
J., 4(14): 3256-60, 1990 |
|
111
|
Vimy, M.J., et al.: Am. J. Physiol.,
258(Pt. 2): R939-45, 1990 |
|
112
|
Vimy et al.: Mercury from maternal
"silver" tooth fillings in sheep and human breast milk.
Biological Trace Element Research, V56, pp143,
1997 |
| 113 |
Wenstrup, D., et al.: Trace element
imbalances in isolated subcellular fractions of Alzheimer's
disease brains. Department of Chemistry, University
of Kentucky, Lexington. Brain Res., 533:1, 125-31,
1990 |
| 114 |
Nylander, M., et al.: Mercury concentrations
in the human brain and kidneys in relation to exposure
from dental amalgam fillings. Swe. Dent. J., 11:5,
179-87, 1987 |
| 115 |
Friberg, L. et al.: Kvicksilver I
centrala nervsystemet I relation till amalgamfyllningar
(Mercury in the central nervous system in relation to
dental amalgam). Lakartidningen, 83:519-22, 1986
|
| 116 |
Eggelston, D.W., et al.: Correlation
of dental amalgam with mercury in brain tissue. J.
Pros. Dent., 58: 704-7, 1987 |
| 117 |
Schiele et al. in 1984 |
| 118 |
Nylander, M., et al.: Mercury concentration
in the human brain and kidneys in relation to exposure
from dental amalgam fillings. Swed. Dent. J., 11(5):
179-87, 1987 |
| 119 |
Weiner, J.A. and Nylander, M.: The
relationship between mercury concentration in human organs
and different predictor variables. National Board of
Occup. Safety and health, Solna, Sweden. Sci-Total-Environ.,
138(1-3): 101-15, 1993 |
| 120 |
Drasch, G., et al.: Silver concentrations
in human tissues, their dependence on dental amalgam and
other factors. Trace Elements in Medicine and Biology,
9(2): 82-7, 1995 |
| 121 |
Smith, D.H.: Science, 156,
1114, 1967 |
| 122 |
Duhr, E. et al.: Hg2+ induces GTP-tubulin
interactions in rat brain similar to those observed in
Alzheimer's disease. FASEB, 75th Annual Meeting, Atlanta,
Georgia, 21.25 April 1991, Abstract 493 |
| 123 |
Pendergrass, J. et al.: The deleterious
effects of low micromolar mercury on important brain and
cerebrospinal fluid protein. American Association of
pharmaceutical scientists, Annual Meeting, 5-9 November,
1995, Miami |
| 124 |
Pendergrass, J.C. et al.: Mercury
vapor inhalation inhibits binding of tubulin in rat brain:
Similarity to a molecular lesion in Alzheimer disease
d brain. Neurotoxicology, In Press June-July 1997
|
| 125 |
Lorscheider, F.L., et al.: Toxicity
of ionic mercury and elemental mercury vapour on brain
neuronal protein metabolism. 1994 |
| 126 |
Summers, A.O. et al.: Mercury released
from dental "silver" fillings provokes an increase in
mercury- and antibiotic-resistant bacteria in oral and
intestinal floras of primates. Antimicrob. Agents Chemother.
37(4): 825-34, 1993 |
| 127 |
Edlund, C. et al.: Resistance of
the normal human microflora. Mercury and antimicrobials
after exposure to mercury from dental amalgam fillings.
Clin. Inf. Dis. 22(6): 944-950, June 1996 |
| 128 |
Liebert, C.A. et al.: The impact
of mercury released from dental "silver" fillings on antibiotic
resistances in the primate oral and intestinal bacterial
flora. Met. Ions. Biol. Syst., 34:441-60, 1997 |
| 129 |
Catsakis, L.H., Sulica, V.I.: Allergy
to silver amalgams. Oral Surg. Oral Med. Oral Pathol.,
46(3): 371-5, 1978 |
| 130 |
Stejskal, V.D.M., et al.: The lymphocyte
transformation test for diagnosis of drug-induced occupational
allergy., Journal of Allergy and Clinical Immunology
77, 411-426 |
| 131 |
Stejskal, V.D.M. et al.: Lymphocyte
transformation test for diagnosis of isohia-zolinone allergy
in man., J. of Investigative Derma-tology 94, 798-902 |
| 132 |
Stejskal, V.D.M. et al.: Allergy
to drugs and other chemicals diagnosed by the presence
of specific memory cells in human blood. In realm of tolerance.
Edited by P. Ivanyi. Pp. 213-224. Springer-Verlag, Berlin
|
| 133 |
Wilhelm-M, Dunninger, P. et al.:
Effects of amalgam on cells of the immune system. Einfluss
von Amalgam auf Zellen des Immunsystems. Med. Poliklinik
der Universität Würzburg, Dtsch. Zahnärztl. Z., 46(8):
544-7, 1991 |
| 134 |
Adverse immunological effects and
autoimmunity induced by dental amalgam and alloy in mice.
Hultmann: FASEB J, 8(14): 1183-90, 1994 |
| 135 |
Hultman: Murine mercury-induced immune-complex
disease: effect of cyclophosphamide treatment and importance
of T-cells., Br. J. Exp. Pathol., 70(3): 227-36,
1989 |
| 136 |
Hultman: Murine susceptibility to
mercury. II. Autoantibody profiles and renal immune deposits
in hybrid backcross and H-2d congenic mice. Clin. Immunol.
Immunolpathol. 68(1): 9-20, 1993 |
| 137 |
Enestrom, S., Hultman, P.: Does amalgam
affect the immune system? A controversial issue.; Int.
Arch. Allergy Immunol., 106(3): 180-203, 1995 |
| 138 |
Warfvinge, G., Larsson, A.: Contact
stomatitis to mercury associated with spontaneous mononuclear
cell infiltrates in brown Norway (BN) rats with HgCl2-induced
autoimmunity. J. Oral Pathol. Med. 23(10): 441-5,
1994 |
| 139 |
Kosuda, L.L.; et al.: Mercury-induced
renal autoimmunity in BN'LEW. 1N chimeric rats., Cell.
Immunol. 155(1): 77-94, 1994 |
| 140 |
Sato, K., et al.: An Epidemiological
study of mercury sensitization. Allergology International,
46:201-6, 1997 |
| 141 |
Summers, A.O., Sugarman, L.I.; J.
Bacteriol. 119, 242, 1974 |
| 142 |
Katsunuma Exercise-induced anaphylaxis:
improvement after removal of amalgam in dental caries.,
Ann. Allergy, 64(5): 472-5, 1990 |
| 143 |
Caron, G.A., et al.: Lympho-cyte
transformation induced by inorganic and organic mercury.,
International Archives of Allergy 37, 76 87 |
| 144 |
Bolewska, J., et al.: Oral mucosal
lesions related to silver amalgam restorations., Department
of Oral Medicine and Oral Surgery, University Hospital,
Copenhagen, DK, Oral-Surg. Oral-Med.Oral-Pathol., 70(1):
55-8, 1990 |
| 145 |
Finne, K. et al.: Oral lichen planus
and contact allergy to mercury. International Journal
of Oral Surgery 11, 236-239 |
| 146 |
Laine, J., et al.: Resolution of
oral lichenoid lesions after replacement of amalgam restoration
in patients allergic to mercury compounds. Br. J. Dermatol.,
126(1). 10-5, 1992 |
| 147 |
Stejskal, V.D.M., et al.: Mercury-specific
lymphocytes: an indication of mercury allergy in man.
J. Clin. Immunol., 16(1): 31-40, 1996 |
| 148 |
Henriksson, E., et al.: Healing of
lichenoid reactions following removal of amalgam. A clinical
follow-up. J. Clin. Periodontol., 22(4): 287-94,
1995 |
| 149 |
Smart, E.R., et al.: Resolution of
lichen planus following removal of amalgam restorations
in patients with proven allergy to mercury salts: a pilot
study. Br. Dent. J., 178(3): 108-12, 1995 |
| 150 |
Mobacken, H. et al.: Material.
Cont. Derm., 10: 11-15, 1984 |
| 151 |
Macleod, R.I. et al.: J. Dent.
Res., Divisional Abstracts, page 738, Abstract # 410,
1993 |
| 152 |
Schrallhammer-Benkler, K., et al.:
Acta derm. Venerol (Stockh)71(4): 294-6, 1992 |
| 153 |
Ahlrot-Westerlund, B.: Mercury in
cerebrospinal fluid in multiple sclerosis. Swed. J.
Biol. Med., 1:6, 1989 |
| 154 |
Stejskal, V.D.M. et al.: J. of
Clin. Immun. Vol 16, No. 1, pp. 31-40, 1996 |
| 155 |
Siblerud, R.L.: A comparison of mental
health of multiple sclerosis patients with silver/mercury
dental fillings and those with fillings removed. Psychol.
Rep., 70:3 Pt 2, 1139-51, 1992 |
| 156 |
Ingalls, T.H.: Epidemiology, etiology,
and prevention of multiple sclerosis. Hypothesis and fact.
Am. J. Forensic Med. Pathol., 4:1, 55-61, 1983
|
| 157 |
Siblerud, R.L., Kienholz, E.: Evidence
that mercury from silver amalgam fillings may be an etiological
factor in multiple sclerosis. Sci. Total Environ.,
142(3): 191-205, 1994 |
| 158 |
Craelius, W.: Comparative Epidemiology
of multiple sclerosis and dental caries. J. Epidemiology
and Community Health, 32, 155-165, 1978 |
| 159 |
Huysmans, M.C. et al.: Fatigue behavior
of direct post-and-core-restored premolars. J. Dent.
Res., 71(5): 1145-50, 1992 |
| 160 |
Huysmans, M.C., et al.: Finite element
analysts of quasistatic and fatigue failure of post and
cores [published erratum appears in J.Dent. Res.,
21(3):190] J. Dent., 21(1): 57-64, 1993 |
| 161 |
Siblerud, R.L.: The relationship
between mercury from dental amalgam and the cardiovascular
system. Sci. Total Environ., 99(1-2): 23-35, 1990 |
| 162 |
Ronnback, L., Hansson, E.: Chronic
encephalopaties induced by mercury or lead: aspects of
underlying cellular and molecular mechanisms. Br. J.
Ind. Med., 49: 233-240, 1992 |
| 163 |
McNerney, R.T., McNerney J.J.: Mercury
contamination in the dental office. A review. NYS Dental
J., pp 457-458, 1979 |
| 164 |
Sandborgh Englund, G., et al.: DMSA
administration to patients with alleged mercury poisoning
from dental amalgams: a placebo-controlled study. J.
Dent. Res., 73(3): 620-8, 1994 |
| 165 |
Weaver, T., et al.: An amalgam tattoo
causing local and systemic disease? Oral Surg Oral
Med Oral Pathol, 63(1): 137-40, 1987 |
| 166 |
Siblerud, R.L., et al.: Psychometric
evidence that mercury from silver amalgam fillings may
be an etiological factor in depression, excessive anger
and anxiety. Psychol. Rep., 74(1): 67-80, 1994
|
| 167 |
Michel, E., et al.: An epidemiologic
study of the relation between symptoms of fatigue, dental
amalgam and other factors. Department of occupational
medicine, University Hospital, Uppsala, Sweden, Sew-Dent-J.,
13(1-2): 33-8, 1989 |
| 168 |
Florentine, M.J., Sanfilippo, D.J.,
II. Elemental mercury poisoning clinical pharmacy. 10:
213-21, 1991 |
| 169 |
Benton, D., et al.: The impact of
selenium supplementation on mood. Biological Psychiatry,
9(11): 1092-1098, 1991 |
| 170 |
Bloch, P., Shapiro I.M.: Summary
of the international conference on mercury hazards in
dental practice. JADA, 104: 489-90, 1982 |
| 171 |
Silverstein: Modulation of heart
muscle mitochondrial malate dehydrogenase activity. I.
Activation and inhibition by p-mercuribenzoate. Biochemistry,
9(2): 274-82, 1970 |
| 172 |
Differential effects of mercurial
reagents on membrane thiols and on the permeability of
the heart mitochondrion. Biochemistry, 9(4): 714-24,
1970 |
| 173 |
Manoukian, S.V., Wenger, N.K.: Mercury
in the heart. Am. J. Cardiol., 67(4): 317-8, 1991 |
| 174 |
Shimojo, N., Arai, Y.: Effects of
exercise training on the distribution of metallic mercury
in mice. Hum Exp Toxicol., 13(8): 524-528, 1994 |
| 175 |
Magos, L., et al.: The effects of
dose of elemental mercury and first-pass circulation time
on exhalation and organ distribution of inorganic mercury
in rats. Biochem Biophys Acta. 25; 991(1):85-9,
1989 |
| 176 |
Lindh, U., et al.: New Aspects of
Murine Coxsackie B3 Myocarditis - Focus on Heavy Metals.
Ilback, NG; Eur Heart J., 16(Suppl 0):20-4, 1995
|
| 177 |
Omura, Y., Shimotsnura, Y., Fukuoka,
A., Fukuoka, H., Nomoto, T.: Significant mercury deposits
in internal organs following the removal of dental amalgam,
and development of pre-cancer on the gingiva and the sides
of the tongue and their represented organs as a result
of inadvertent exposure to strong curing light (used to
solidify synthetic dental filling material) and effective
treatment: A clinical case report, along with organ representation
areas for each tooth. Acupunct Electrother Res.,
21(2):133-60, 1996 |
| 178 |
Foster, H.D.: Landscapes of Longevity:
The Calcium-Selenium Mercury connection in cancer and
heart disease. Med Hypotheses, 48(4): 355-60, 1997 |
| 179 |
Chavez, E. and Holguin, J.A.: Mitochondrial
calcium release as induced by Hg2+. J. Biol. Chem.,
263(8):3582-3587, 1988 |
| 180 |
Chen, C.W. and Preston, R.L.: Effect
of mercury on taurine transport by the red blood cells
of the murine polychate, Glycera dibranciata. Bull
Environ. Contam. Toxicol., 39(2): 202-208, 1987 |
| 181 |
Mehra, M. and Kanwar, K.C.: Clearance
of parenterally administered 203 Hg from the mouse tissues.
J. Environ. Pathol. Toxicol. Oncol., 5(4-5): 127-30,
1984 |
| 182 |
Brake, J., et al.: Mercury induced
cardiovascular abnormalities in the chicken. Arch.
Environ. Contam. Toxicol., 6(2-3): 269-77, 1977 |
| 183 |
Mechanisms in cardiovascular regulation
following chronic exposure of male rats to inorganic mercury.
Toxicol. Appl. Pharmacol., 69(3):442-50, 1983 |
| 184 |
Klein, C.L., et al.: Increased adhesion
and activation of polymorphonuclear neutropohil granulocytes
to endothelial cells under heavy metal exposure in vitro.
Pathobiology, 62(2): 90-98, 1994 |
| 185 |
Ringstad, I. & Fonnebo, V.: The tromso
heart study: serum in a low-risk population for cardiovascular
disease and cancer and matched controls. Ann. Clin.
Res., 19:351-54, 1987 |
| 186 |
Wojciechowski, J. and Kowalski, W.:
Cardiac and aortic lesions in chronic experimental poisoning
with mercury vapors. Pol. Med. Sci. Hist. Bull.,
15(2): 255-60, 1996 |
| 187 |
Schottel, J., et al.: Nature, 251,
335, 1974 |
| 188 |
Marcusson, J.A.: Psychological and
somatic subjective symptoms as a result of dermatological
patch testing with metallic mercury and phenyl mercuric
acetate. Toxicol. Lett., 84(2): 113-22, 1996 |
| 189 |
Lamperti, A. and Printz, R.: Localization,
accumulation and toxic effects of mercuric chloride on
the reproductive axis of the female hamster. 11; 180-86,
1974 |
| 190 |
Lamperti, A. and Niewenhuis, T.:
The effects of mercury on the structure and function of
the hypothalamo-pituitary axis in the hamster. Cell.
Tissue Res., 170; 315-324, 1976 |
| 191 |
Mikhailova, L., et al.: The influence
of occupational factors on diseases of the female reproductive
organs. Pediatr. Akush. Ginecol., 33; 56-58, 1971
|
| 192 |
Panova, Z. and Dimitrov, G.: Ovarian
function in women with occupational exposure to metallic
mercury. Akush. Ginekol., 13; 29-34, 1974 |
| 193 |
Goncharuk, G.: Problems relating
to the occupational hygiene for women employed in mercury
production. Gig. Tr. Prof. Zabol., 5; 17-20, 1977 |
| 194 |
Barlow, S. and Sullivan, F.: "Mercury
and its compounds (inorganic)", in Barlow, S. and Sullivan,
F. Editors, Reproductive hazards of industrial chemicals:
an evaluation of animal and human data, New York and
London: Academic Press |
| 195 |
DeRosis, F. et al.: Female reproductive
health in two lamp factories: effects of exposure to inorganic
mercury vapor and stress factors. Br. J. Ind. Med.,
42; 488-494, 1985 |
| 196 |
Sikorski, R. et al.: Women in dental
surgeries: Reproductive hazards in occupational exposure
to metallic mercury. Int. Arch. Occup. Environ. Health,
59; 551-7, 1987 |
| 197 |
Iwasaki, A. and Gagnon, C.: Formation
of reactive oxygen species in spermatozoa of infertile
patients. Fertil Steril, 57(2): 409-16, 1992 |
| 198 |
Aitken, R. et al.: Use of xanthine
oxidase free radical generating system to investigate
the cytotoxic effects of reactive oxygen species on human
spermatozoa. J. Reprod. Fertil., 97(2): 441-50,
1993 |
| 199 |
Webb, J.: Enzyme and metabolic inhibitor,
Volume 4, Academic Press, 727-1070, 1966 |
| 200 |
Hirota, Y. et al.: Inhibitory effect
of methyl mercury on the activity of glutathione peroxidase.
Toxicol. Appl. Pharmacol., 53; 174-6, 1980 |
| 201 |
Holmstrup, P.: Oral mucosa and skin
reaction related to amalgam. Adv. Dent. Res., 6:120-4,
1992 |
| 202 |
Bradberry, S.M., et al.: Elemental
mercury-induced skin granuloma: a case report and review
of the literature. J. Toxicol. Clin. Toxicol., 34(2):
209-16, 1996 |
| 203 |
Hamdy, M.K. and Noyes, O.R.: Formation
of methyl mercury by bacteria. Applied Microbiology,
Vol 30, No. 3, 424-432, 1975 |
| 204 |
Langworth, S., et al.: Minor effects
of low exposure to inorganic mercury on the human immune
system. Sacnd. J. Work. Environ. Health, 19(6):
405-13, 1993 |
| 205 |
Sasaki, G., et al.: Three cases of
linear lichen planus caused by dental metal compounds.
Dermatol., 23:12 890-2, 1996 |
| 206 |
Bass, M.H.: Idiosyncrasy to metallic
mercury, with special reference to amalgam fillings in
the teeth. J. Pediat., 23: 215-8, 1943 |
|
207
|
Cooper, R.L., et al.: Effects of
metal cations on pitiuary hormone secretion in vitro.
J. Biochem. Toxicol., 2: 241-9, 1987 |
| 208 |
Gerhard, I. & Runnebaum, B.: Fertility
disorders may result from heavy metal and pesticide contamination
which limits effectiveness of hormone therapy. Zentralblatt
für Gynäkologie, 14: 593-602, 1992 |
| 209 |
Summers, A.O.and Lewis, E.: J.
Bacterial., 113, 1070, 1973 |
| 210 |
Bakir, F. et al.: Clinical and epidemiological
aspects of methyl mercury poisoning. Postgrad. Med.
J., 56(651):1-10, 1980 |
| 211 |
Murai, Y., Shiraishi, S., Yamashita,
Y., Ohnishi, A., Arimura, K.: Neurophysiological effects
of methyl mercury on the nervous system. Electroencephalogr.
Clin. Neurophysiol. Suppl., 36: 682-7, 1982 |
| 212 |
Brunker, R.L. and Bott, T.L.: Reduction
of mercury to the elemental state by a yeast. Appl.
Microbiology, Vol. 27, No. 5, 870-3, 1974 |
| 213 |
Martinez Vazquez, C. et al.: Evoked
potentials and psychometric tests in the diagnosis of
subclinical neurological damage in a group of workers
exposed to low concentrations of mercury vapor (see comments).
An. Med. Interna., 13(5): 211-6, 1996 |
| 214 |
Pan Hou, H.S. and Imura, N.: Involvement
of mercury Methylation in microbial mercury detoxification.
Arch. Microbiol., 131: 176-177, 198 |
| 215 |
Bisogni, J.J. and Lawrence, A.W.:
Kinetics of mercury Methylation in aerobic and anaerobic
aquatic environments. J. Water Pollut. Control. Fed.,
47: 135-152, 1975 |
| 216 |
Hua, M.S. et al.: Chronic elemental
mercury intoxication: Neuropsychological follow-up case
study. Brain Inj., 10(5): 377-84, 1996 |
| 217 |
Snapp, K. et al.: Contribution of
dental amalgam to blood mercury levels. J. Dent. Res.,
Special Issue March 1986, Abstract fl. 276, 65; 311 |
| 218 |
Nilsson, B. and Nilsson, B.: Mercury
in blood and urine in dental personnel. Swed. Dent.
J., 2: 280, 1987 |
| 219 |
Gowdy, J.M., and Demers, F.X.: Whole
blood mercury levels in mental hospital patients. Am.
J. Psychiat., 135: 115, 1978 |
| 220 |
Richter-Snapp, K. et al.: The contribution
of dental amalgam to mercury in blood. J. Dent. Res.,
68: 314, Abstract 1059, 1989 (Dows Inst. For Dent. Res.,
University of Iowa) |
| 221 |
Magos, L.: Mercury-blood interaction
and mercury uptake by the brain after vapor exposure.
Environ. Res., 1: 323-37, 1967 |
| 222 |
American Dental Assoc. Workshop:
Biocompatibility of metals in dentistry (NIDR). A recommended
standard for occupational exposure to inorganic mercury.
NTIS No. PB- 222 223, 1973 |
| 223 |
Grandjean, P., et al.: Neurotoxicol.
Teratol., 19(6): 417-28, 1997 |
| 224 |
Heintze, U. et al.: Methylation of
mercury from dental amalgam and mercuric chloride by oral
streptococci. Scand. J. Dent. Res., 91:2, pp 150-52,
1983 |
| 225 |
Rowland, A.S., et al.: The effect
of occupational exposure to mercury vapor on the fertility
of female dental assistants. Occup. Environ. Med.,
51(1): 28-34, 1994 |
| 226 |
Mandel, I: JADA Vol. 122,
1991 |
| 227 |
Gordon, H.P. and Cordon, L.D.: Reduction
in mercury vapour levels in Seattle dental offices.
J. Dent. Res., Abstract 1092 57A:347, 1981 |
| 228 |
Akesson, et al.: Archives of environmental
health, v62, n2, p102(8), 1991 |
| 229 |
Cross, J.D., et al.: Letter,
Lancet, 2: 8084 pp312-13, 1978 |
|
230
|
Danielsson, B.R., et al.: Behavioral
effects of prenatal metallic mercury exposure in rats.
Neurotoxicol. Teratol., 15(6): 391-396,
1993 |
| 231 |
Nylander: Mercury in pituitary glands
of dentists. Lancet, 1(8478): 442, 1986 |
| 232 |
Akesson, I., et al.: Neuropathy in
female dental personnel exposed to high frequency vibrations.
Occup. Environ. Med., 52(2): 116-23, 1995 |
| 233 |
Skare: Mercury exposure of different
origins among dentists and dental nurses. Scand. J.
Work Environ. Health, 16(5): 340-7, 1990 |
| 234 |
Wood, R.W., et al.: Hand tremor induced
by industrial exposure to inorganic mercury. Arch.
Environ. Health, 26: 249-52, 1973 |
| 235 |
Mantyla, D.G. and Wright, O.D.: Mercury
toxicity in the dental office: a neglected problem. JADA,
92: 1189-94, 1976 |
| 236 |
Fredriksson, A. et al.: Prenatal
Coexposure to metallic mercury vapour and methyl mercury
produce interactive behavioral changes in adult rats.
Neurotoxicol. Teratol., 18(2): 129-34, 1996 |
| 237 |
Oskarsson, A., et al.: Exposure to
toxic elements via breast milk. Analyst, 120(3):
765-70, 1995 |
| 238 |
Shapiro, I.M., et al.: Neurophysiological
and neuropsychological function in mercury-exposed dentists.
Lancet, 8282: 1147-50, 1982 |
| 239 |
Ship, I.I. and Shapiro, I.M.: Mercury
poisoning in dental practice. Compendium Continuing
Education. 4: 107-110, 1983 |
| 240 |
Miller, J.M., et al.: Subclinical
psychomotor and neuromuscular changes in workers exposed
to inorganic mercury. A. Indus. Hyg. Assoc. J.,
36: 725-33, 1975 |
| 241 |
Lyer, K., et al.: Mercury poisoning
in a dentist. Arch. Neurol., 33:788-90, 1976 |
| 242 |
Merfield, D.P., et al.: Mercury intoxication
in a dental surgery following unreported spillage. Bril.
Dent. J., 141: 179-86, 1976 |
| 243 |
Barber, T.E.: Inorganic mercury intoxication
reminiscent of amyotrophic lateral sclerosis. J. Occupat.
Med., 20: 667-9, 1978 |
| 244 |
Smith, Jr. D.L.: Mental effects of
mercury poisoning. South Med. J., 71: 904-5, 1978
|
| 245 |
Langolf, G.D., et al.: Evaluation
of workers exposed to elemental mercury using quantitative
tests of tremor and neuromuscular functions. Am. Ind.
Hyg. Assoc., 39(12): 976-84, 1978 |
| 246 |
Zweben, L.L.: Mercury poisoning:
A case history. J. New Jersey Dent. Assoc., 10-1,
1978 |
| 247 |
Albers, J.W. et al.: Asymptomatic
sensorimotor polyneuropathy in workers exposed to elemental
mercury. Neurology, 32: 1168-74, 1982 |
| 248 |
Adams, C.R., et al.: Mercury intoxication
simulating amyotrophic lateral sclerosis. J. Amer.
Med. Assoc., 250:642-3, 1983 |
| 249 |
Cook, T.A. and Yates, P.O.: Fatal
mercury intoxication in dental surgery assistant. Br.
Dent. J., 127: 553-5, 1969 |
| 250 |
Ritchie, K.A. et al.: Psychomotor
testing of dentists with chronic low-level mercury exposure.
J. Dent. Res., 74(S1): 420, A-160 |
| 251 |
Schumann, K.: The toxicological estimation
of the heavy metal content (Cd, Hg, Pb) in food for infants
and small children. Z. Ernährungswiss., 29(1):
54-73, 1990 |
| 252 |
Vimy et al.: Maternal-fetal distribution
of mercury released from dental amalgam fillings. Am.
J. Physiol., 258 R939-R945, 1990 |
| 253 |
Vimy et al.: Mercury from maternal
"silver" tooth fillings in sheep and human breast milk.
Biological Trace Element Research, V56, pp143,
1997 |
| 254 |
Warfinge, K., et al.: Development
of prenatal exposure to mercury vapor. Neurotoxicology,
15(4), 1994 2 |
| 255 |
55 Cutright, D.E., et al.: Systemic
mercury levels caused by inhaling mist during high-speed
amalgam grinding. J. Oral Med., 28, 100, 1973 |
| 256 |
EPA Mercury Health Effects update.
Health Issue Assessment. EOA-600/8-84f. USEPA,
1984 |
| 257 |
Goyer, R.A.: Toxic effects of metals.
Cassarett and Doull's toxicology - The basic science of
poisons, ed3, New York, MacMillan, Publ. Co, pp582-609,
1986 |
| 258 |
Kuhnert, P. et al.: Comparison of
mercury levels in maternal blood fetal chord and placental
tissue. Am. J. Obstet and Gynecol., 139: 209-12,
1981 |
| 259 |
Kuntz, W.D.: Maternal and chord blood
mercury background levels; Longitudinal surveillance.
Am. J. Obstet and Gynecol., 143: 440-443, 1982
|
|
260
|
Brodsky, J.B.: Occupational exposure
to mercury in dentistry and pregnancy outcome. JADA
111(11): 779-80, 1985 |
| 261 |
Yoshida, M., et al.: Milk transfer
and tissue uptake of mercury in suckling offspring after
exposure of lactating maternal guinea pigs to inorganic
or methyl mercury. Arch. Toxicol., 68(3): 174-8,
1994 |
| 262 |
Ellender, G., et al.: Toxic effects
of dental amalgam implants. Optical, histological and
histochemical observations. Aust. Dent. J., 23:5
pp395-99, 1978 |
| 263 |
Fisher, D., et al.: A 4 year follow-up
study of alveolar bone height influenced by 2 dissimilar
class 2 amalgam restorations. |
| 264 |
Freden, H., et al.: Mercury content
in gingival tissues adjacent to amalgam fillings. Odont.
Rev., 25: 207-210, 1974 |
| 265 |
Koivumaa, K.K. and Makila, E.: The
effect of galvanism on accumulation of bacterial plaque
invivo. Suom Hammaslaak Toim., 66: 367-371, 1970 |
| 266 |
Lindquist & Mornstad: Effects of
removing amalgam fillings from patients with diseases
affecting the immune system. Medical Science Research.,
24, 1996 |
| 267 |
Bratel, J., et al.: Effect of replacement
of dental amalgam on oral lichenoid reactions. J. Dent.,
24(1-2): 41-45, 1996 |
| 268 |
Ibbotson, S.H., et al.: The relevance
and effect of amalgam replacement in subjects with oral
lichenoid reactions. Br. J. Dermatol., 134(3):
420-3, 1996 |
| 269 |
James, J., et al.: Oral lichenoid
reactions related to mercury sensitivity. Br. J. Oral
Maxillofac. Surg., 25(6): 474-480, 1987 |
| 270 |
Jameson, M.W. et al.: Mucosal reactions
to amalgam restorations. J. Oral Rehabil., 17(4):
293-301, 1990 |
| 271 |
Koch, P. and Bahmer, F.A.: Oral lichenoid
lesions, Hg hypersensitivity and combined hypersensitivity
to mercury and other metals. Contact Dermatitis,
33(5): 323-328, 1995 |
| 272 |
Lind, P.O., et al.: Electrogalvanically-induced
contact allergy of the oral mucosa. Report of a case.
Int. J. Oral Surg., 13(4):339-345, 1984 |
| 273 |
Lind, P.O., et al.: Amalgam-related
oral lichenoid reaction. Scand. J. Dent. Res.,
94(5): 448-451, 1986 |
| 274 |
Pang, B.K. and Freeman, S.: Oral
lichenoid lesions caused by allergy to mercury in amalgam
fillings. Contact Dermatitis, 33(6): 423-427, 1995 |
| 275 |
Skoglund, A. and Egelrud, T.: Hypersensitivity
reactions to dental materials in patients with lichenoid
oral mucosal lesions and in patients with burning mouth
syndrome. Scand. J. Dent. Res., 99(4): 320-8, 1991 |
| 276 |
Fox, J.G. and Jones, J.M.: Occupational
stress in dental practice. B.D.J., 123:10 pp 465-473,
1967 |
| 277 |
Iyer, K., et al.: Mercury poisoning
in a dentist. Arch. Neurol., 33: pp788-90,
1976 |
| 278 |
Ship, I.I. and Shapiro, I.M.: Preventing
mercury poisoning in dental practice. The J. of the
Houston District Dental Society, pp18-20, 1983 |
| 279 |
Simpson, R., et al.: Suicide statistics
of dentists in Iowa 1968-1980. JADA 107, 441-3,
1983 |
| 280 |
Fox, C.H., et al.: Periodontal disease
among New England elders. Journal of Periodontology,
Vol 65, No. 7, pg. 676-684, 1994 |
| 281 |
Mattila, K.J. et al.: Association
between dental health and acute myocardial infarction.
British Medical J., Vol. 298, pg 779-782, 1989 |
| 282 |
DeStefano, F.D., et al.: Dental disease
and risk of coronary heart disease and mortality. Br.
Med. J., Vol. 306, 688-691, 1993 |
| 283 |
Joshipura, K.J. et al.: Poor oral
health and coronary heart disease. Journal of dental Research,
Vol. 75, No. 9, 1631-1636, 1996 |
| 284 |
Beck, J.D.: Periodontal disease and
cardiovascular disease. Presented at the symposium: The
relation of periodontal infection to systemic diseases.
Bufallo N.Y., May 20, 1995 |
| 285 |
Offenbacher, S., et al.: Periodontal
infection as a possible risk factor for preterm low birth
weight. J. Periodontology, 1996 |
| 286 |
Pendergrass and Haley: Mercury and
its effects on environment and biology in metal ions in
biological systems. V 34, 461-478, 1997, Marcel Dekker,
Inc. NY, NY |
| 287 |
Brun, R.: Epidemiology of contact
dermatitis in Geneva. Contact dermatitis, 1: 214-7,
1975 |
| 288 |
Djerassi, E. and Berova, N.: The
possibilities of allergic reactions from silver amalgam
restorations. Int. Dent. J., 19:4, 481-88, 1969 |
| 289 |
Miller, E.G., et al.: Prevalence
of mercury hypersensitivity in dental students. J.
Dent. Res., 64:338 Special issue abstracts # 1472,
1985 |
| 290 |
Nebenfuher, L., et al.: Mercury allergy
in Budapest. Contact Dermatitis, 10(2): 121-122,
1983 |
| 291 |
Rudner, et al.: Epidemiology of
contact dermatitis in North America. Arch. Derm.,
108(4): 537-40, 1973, 1996 |
| 292 |
White, R. and Brandt, R.: Development
of mercury hypersensitivity among dental students. JADA,
92: 1204-1207, 1976 |
| 293 |
Ahlbom, A. et al.: Dentists, Nurses
and Brain Tumors: 4th International Symposium Epidemiology
Occupational Health, Como, Italy, 10-12 September
1985 (Abstracts) |
| 294 |
Arrhenius, E.: Methyl mercury in
fish - a toxicologic-epidemiologic evaluation. Nord
Hygien. Tidskr., suppl 4, pp166, 1971 |
| 295 |
Kuntz, W.D., et al.: Maternal and
chord blood background mercury levels: A longitudinal
surveillance. Am. J. Obstet. Gynecol., pp440-443,
1982 |
| 296 |
Mansour, M., et al.: Maternal-fetal
transfer of organic mercury via placenta and milk.
Env. Res., 6: pp 479-484, 1973 |
| 297 |
Nixon, G.S., et al.: Pregnancy outcome
in female dentists. B.D.J. 146, pp 39-42, 1979
|
| 298 |
Pitkin, R.M. et al.:
Mercury in human maternal and cord blood, placenta and
milk. Proceedings of the society for experimental biology
and medicine, 151 pp565-567, |
|
|

|
|
|